Triptolide Attenuates Inflammatory Response in Membranous Glomerulo-Nephritis Rat via Downregulation of NF-κB Signaling Pathway

Kidney and Blood Pressure Research

Volumn 41, Issue 6, 2016, Pages 901-910

  Zhou, Ying ^a   Hong, Yan ^a   Huang, Haihua ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Glomerulonephritis; Inflammatory; Signaling pathway; Triptolide

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE INHIBITOR; IMD 0354; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TRIPTOLIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; DITERPENE; EPOXIDE; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; GLOMERULONEPHRITIS, MEMBRANOUS; INFLAMMATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DITERPENES; DOWN-REGULATION; EPOXY COMPOUNDS; GLOMERULONEPHRITIS, MEMBRANOUS; INFLAMMATION; MALE; NF-KAPPA B; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84996655372     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000452591     Document Type: Article

References (40)

1. Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, Iijima K, Yoshikawa N: Segmental membranous glomerulonephritis in children: Comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol 2006;1:723-729.
2. Wang PR, Kitamura H, Shimizu A, Yamanaka N: Glomerular damage in experimental proliferative glomerulonephritis under glomerular capillary hypertension. Kidney Blood Press Res 2015;40:188-199.
3. Impellizzeri D, Esposito E, Attley J, Cuzzocrea S: Targeting inflammation: New therapeutic approaches in chronic kidney disease (ckd). Pharmacol Res 2014;81:91-102.
4. Ritter C, Zhang S, Finch JL, Liapis H, Suarez E, Ferder L, Delmez J, Slatopolsky E: Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats. Kidney Blood Press Res 2014;39:340-352.
5. Ronco P, Debiec H: Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat Rev Nephrol 2012;8:203-213.
6. Xiong J, Wang Y, Shao N, Gao P, Tang H, Su H, Zhang C, Meng XF: The expression and significance of nlrp3 inflammasome in patients with primary glomerular diseases. Kidney Blood Press Res 2015;40:344-354.
7. Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH: Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Kidney Int 2008;74:596-612.
8. Lin N, Liu C, Xiao C, Jia H, Imada K, Wu H, Ito A: Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol 2007;73:136-146.
9. Tao X, Younger J, Fan FZ, Wang B, Lipsky PE: Benefit of an extract of tripterygium wilfordii hook f in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735-1743.
10. Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, Kempf P, Kivitz A, Sherrer Y, Pucino F, Csako G, Costello R, Pham TH, Snyder C, van der Heijde D, Tao X, Wesley R, Lipsky PE: Comparison of tripterygium wilfordii hook f versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial. Ann Intern Med 2009;151:229-240, W249-251.
11. Graziose R, Lila MA, Raskin I: Merging traditional chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 2010;7:2-12.
12. Wang X, Zhang L, Duan W, Liu B, Gong P, Ding Y, Wu X: Anti-inflammatory effects of triptolide by inhibiting the nf-kappab signalling pathway in lps-induced acute lung injury in a murine model. Mol Med Rep 2014;10:447-452.
13. Tong X, Zheng S, Jin J, Zhu L, Lou Y, Yao H: Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. Acta Biochim Biophys Sin (Shanghai) 2007;39:89-95.
14. Wei D, Huang Z: Anti-inflammatory effects of triptolide in lps-induced acute lung injury in mice. Inflammation 2014;37:1307-1316.
15. Zhu B, Wang YJ, Zhu CF, Lin Y, Zhu XL, Wei S, Lu Y, Cheng XX: Triptolide inhibits extracellular matrix protein synthesis by suppressing the smad2 but not the mapk pathway in tgf-beta1-stimulated nrk-49f cells. Nephrol Dial Transplant 2010;25:3180-3191.
16. Cao Y, Huang X, Fan Y, Chen X: Protective effect of triptolide against glomerular mesangial cell proliferation and glomerular fibrosis in rats involves the tgf- beta 1/smad signaling pathway. Evid Based Complement Alternat Med 2015;2015:814089.
17. Border WA, Ward HJ, Kamil ES, Cohen AH: Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 1982;69:451-461.
18. Liang CL, Wu JB, Lai JM, Ye SF, Lin J, Ouyang H, Zhan JY, Zhou JY: Protection effect of zhen-wu-tang on adriamycin-induced nephrotic syndrome via inhibiting oxidative lesions and inflammation damage. Evid Based Complement Alternat Med 2014;2014:131604.
19. Bhatt D, Ghosh S: Regulation of the nf-kappab-mediated transcription of inflammatory genes. Front Immunol 2014;5:71.
20. Chen YM, Chiang WC, Yang Y, Lai CF, Wu KD, Lin SL: Pentoxifylline attenuates proteinuria in anti-thy1 glomerulonephritis via downregulation of nuclear factor-kappab and smad2/3 signaling. Mol Med 2015;21:276-284.
21. Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the nf-kappa b transcription factor. Mol Cell Biol 1990;10:2327-2334.
22. Ronco P, Debiec H: Advances in membranous nephropathy: Success stories of a long journey. Clin Exp Pharmacol Physiol 2011;38:460-466.
23. Tomino Y: Pathogenesis and treatment of chronic kidney disease: A review of our recent basic and clinical data. Kidney Blood Press Res 2014;39:450-489.
24. Wu CC, Lu KC, Lin YF, Chen JS, Huang CF, Chen CC, Lin SH, Chu P, Sytwu HK: Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy. J Clin Immunol 2012;32:138-149.
25. Tesar V: Editorial on contributions to nephrology, vol. 181, by prof. Nan chen, entitled: New insights into glomerulonephritis (pathogenesis and treatment). Kidney Blood Press Res 2014;39:229.
26. Libby P: Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr Rev 2007;65:S140-146.
27. Park YM, Won JH, Yun KJ, Ryu JH, Han YN, Choi SK, Lee KT: Preventive effect of ginkgo biloba extract (gbb) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappab in raw 264.7 cells. Biol Pharm Bull 2006;29:985-990.
28. Kawasaki H, Onuki R, Suyama E, Taira K: Identification of genes that function in the tnf-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries. Nat Biotechnol 2002;20:376-380.
29. Honkanen E, Teppo AM, Meri S, Lehto T, Gronhagen-Riska C: Urinary excretion of cytokines and complement sc5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1994;9:1553-1559.
30. Sugita A, Ogawa H, Azuma M, Muto S, Honjo A, Yanagawa H, Nishioka Y, Tani K, Itai A, Sone S: Antiallergic and anti-inflammatory effects of a novel i kappab kinase beta inhibitor, imd-0354, in a mouse model of allergic inflammation. Int Arch Allergy Immunol 2009;148:186-198.
31. Ogawa H, Azuma M, Muto S, Nishioka Y, Honjo A, Tezuka T, Uehara H, Izumi K, Itai A, Sone S: Ikappab kinase beta inhibitor imd-0354 suppresses airway remodelling in a dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clin Exp Allergy 2011;41:104-115.
32. Carillon J, Rouanet JM, Cristol JP, Brion R: Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: Several routes of supplementation and proposal of an original mechanism of action. Pharm Res 2013;30:2718-2728.
33. Stancliffe RA, Thorpe T, Zemel MB: Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. Am J Clin Nutr 2011;94:422-430.
34. Liu X, Ye L, Christianson GJ, Yang JQ, Roopenian DC, Zhu X: Nf-kappab signaling regulates functional expression of the mhc class i-related neonatal fc receptor for igg via intronic binding sequences. J Immunol 2007;179:2999-3011.
35. Palanisamy N, Kannappan S, Anuradha CV: Genistein modulates nf-kappab-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur J Pharmacol 2011;667:355-364.
36. Lee CW, Kim SC, Kwak TW, Lee JR, Jo MJ, Ahn YT, Kim JM, An WG: Anti-inflammatory effects of bangpungtongsung-san, a traditional herbal prescription. Evid Based Complement Alternat Med 2012;2012:892943.
37. Park KI, Kang SR, Park HS, Lee DH, Nagappan A, Kim JA, Shin SC, Kim EH, Lee WS, Chung HJ, An SJ, Kim GS: Regulation of proinflammatory mediators via nf-kappab and p38 mapk-dependent mechanisms in raw 264.7 macrophages by polyphenol components isolated from korea lonicera japonica thunb. Evid Based Complement Alternat Med 2012;2012:828521.
38. Ghosh S, May MJ, Kopp EB: Nf-kappa b and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
39. Song J, Wang Y, Liu C, Huang Y, He L, Cai X, Lu J, Liu Y, Wang D: Cordyceps militaris fruit body extract ameliorates membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the nf-kappab pathway. Food Funct 2016;7:2006-2015.
40. Panzer U, Steinmetz OM, Turner JE, Meyer-Schwesinger C, von Ruffer C, Meyer TN, Zahner G, Gomez-Guerrero C, Schmid RM, Helmchen U, Moeckel GW, Wolf G, Stahl RA, Thaiss F: Resolution of renal inflammation: A new role for nf-kappab1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol 2009;297:F429-439.